Gala vs TMates: Which GLP-1 Provider Is Better?

By Iacob Pastina, Independent Researcher & Publisher

Reviewed & updated September 8, 2026 · Cites primary sources (FDA, NEJM, CMS) · Not medical advice

54 providers verified independently·Independent research·How we rank →

Short answer: TMates scores higher on our rubric, 7.8/10 against 7.2/10. Full reasoning, pricing and the cases where the other one wins are below.

Visit TMates - our pick of these two →or find your match

TMates beats Gala overall, scoring 7.8/10 vs 7.2/10. Published pricing is not a like-for-like monthly comparison: Gala is from $149/mo; TMates is from $158/mo. Choose Gala for patients who want gala's low yearly-plan rate on compounded glp-1, $149/mo microdose or $179/mo with all doses included, and will use its free companion app for daily progress logging. Choose TMates for users who want commitment-discount pricing on compounded glp-1s (semaglutide $158-$249/mo, tirzepatide $167-$297/mo, medication included) or a $99/mo clinical path to brand wegovy or zepbound filled at their own pharmacy.

A side-by-side look at Gala and TMates to help you decide. We compare them on:

•Starting price per month
•Our overall score, out of 10
•Medication type, brand-name or compounded
•Whether they accept insurance
•Who each one is best for

Gala

#30 of 54

7.2/10

Telehealth platform whose compounded GLP-1 line covers semaglutide and tirzepatide, sold as a $149/mo microdose tier and a $179/mo all-doses tier, alongside brand-name Ozempic at $1,299/mo and a 'coming soon' Wegovy pill. Operated by AI Coaching, Inc. of Wilmington, Delaware, with care delivered by OpenLoop-affiliated medical groups; Gala states it provides administrative, technology and management services and does not itself provide medical care. It is LegitScript verified and promotes a free Gala GLP-1 app for in-treatment dosing, weight and side-effect logging.

Visit Gala

Higher Rated

TMates

#10 of 54

7.8/10

Telemedicine platform offering two distinct archetypes: compounded semaglutide and tirzepatide with medication included (semaglutide $158-$249/mo, tirzepatide $167-$297/mo on commitment pricing), and a clinical-service-only path to brand-name Wegovy/Zepbound at $99/mo where the prescription is sent to the patient's pharmacy. Phentermine also available. 2026 expansion added brand-name FDA-approved options.

Visit TMates

Feature	Gala	TMates
Why each one	A free Gala GLP-1 companion app, paired with a $149/mo microdose tirzepatide tier on a yearly commitment plan; confirm the app's availability for your phone before enrolling.	Two-archetype platform: (1) compounded GLP-1s with medication included and steep multi-month commitment discounts; (2) cheap $99/mo clinical service for brand Wegovy/Zepbound where you fill the prescription at your own pharmacy.
Our Score	7.2/10	7.8/10
Headline Price	from $149/mo	from $158/mo
Medication Type	Both	Both
Insurance Accepted	No	Yes
Best For	Patients who want Gala's low yearly-plan rate on compounded GLP-1, $149/mo microdose or $179/mo with all doses included, and will use its free companion app for daily progress logging	Users who want commitment-discount pricing on compounded GLP-1s (semaglutide $158-$249/mo, tirzepatide $167-$297/mo, medication included) or a $99/mo clinical path to brand Wegovy or Zepbound filled at their own pharmacy
Watch out for	Brand-name Ozempic here is $1,299/mo, materially above NovoCare's Wegovy pen $199/mo for the first two 0.25 mg or 0.5 mg fills through December 31, 2026, then $349/mo at standard strengths or $399/mo for Wegovy HD; oral pill from $149/mo, dose-dependent and Hims/Hers pill medication from $149 or pen from $199 plus required membership. Buy brand-name elsewhere; Gala's value is its compounded GLP-1 line.	The $99/mo Wegovy or Zepbound tier buys the prescription and provider oversight only. TMates says it does not dispense or ship the drug, and no price for the medication itself appears on its product or category pages, so your own pharmacy bills you separately (checked 2026-09-03).
Ranking	#30	#10
Get started	Visit Gala	Visit TMates

Pros & Cons Compared

Gala

Pros

+Compounded GLP-1 is $149/mo on the microdose tier or $179/mo with all doses included on the yearly plan, and Gala's about page lists GLP-1 medication from $199/mo on a 3-month plan
+A free Gala GLP-1 app for in-treatment logging, promoted in the footer of every page; first-party logging is uncommon among compounded-only platforms
+OpenLoop-affiliated medical groups + LegitScript verification provide third-party accountability that many compounded-only platforms lack
+All 50 states, free shipping, no insurance required, 24/7 patient support claimed

Cons

−Brand-name Ozempic here is $1,299/mo, materially above NovoCare's Wegovy pen $199/mo for the first two 0.25 mg or 0.5 mg fills through December 31, 2026, then $349/mo at standard strengths or $399/mo for Wegovy HD; oral pill from $149/mo, dose-dependent and Hims/Hers pill medication from $149 or pen from $199 plus required membership. Buy brand-name elsewhere; Gala's value is its compounded GLP-1 line.
−Product pages quote only the yearly subscription, its about page lists a 3-month GLP-1 plan from $199/mo, and the plan you actually get is set at checkout after you log in
−Mixed Trustpilot reviews mention dosing inconsistencies and slow customer service responsiveness, verify your specific dose and batch with each refill
−Initial consultation is typically a sync video visit, but ongoing follow-ups are chat-based (no scheduled ongoing video access), and Gala publishes no lab panel for the GLP-1 program, no named medical director and no specialty obesity oversight; its refund policy does list lab services among what the subscription price may cover
−Restrictive refund policy, Gala's published terms state 'IN NO EVENT SHALL YOU BE ISSUED A REFUND UPON CANCELLATION OF THE SUBSCRIPTION SERVICES' with a narrow exception for provider-initiated medical disqualification. No money-back guarantee. Read the published policy at galaglp1.com/refund-policy before enrolling on a commitment plan
−Newer brand under AI Coaching, Inc. (founded 2024 per LinkedIn), limited public company history; founders, founding year, and named medical director not publicly disclosed on galaglp1.com itself

TMates

Pros

+Clinical-service-only path to brand Wegovy and Zepbound at $99/mo, prescription goes to patient's pharmacy (you fill separately using insurance or cash)
+Steep multi-month commitment discounts on compounded sema, $158/mo on 12-month plan ($1,900 upfront) vs $249/mo month-to-month
+Same price at all dose levels for compounded, no cost escalation as you titrate up
+Phentermine available at $149/mo for patients who benefit from a different appetite-suppressant approach

Cons

−The $99/mo Wegovy or Zepbound tier buys the prescription and provider oversight only. TMates says it does not dispense or ship the drug, and no price for the medication itself appears on its product or category pages, so your own pharmacy bills you separately (checked 2026-09-03).
−The best compounded rates require prepayment: $1,050 upfront for 6 months, $1,900 for 12. Start at $249 month-to-month if you want to test fit first.
−The intake is a 90-second quiz. Fast, but lighter screening than competitors with full medical intakes. Better suited to patients who already know GLP-1 basics.
−TMates prescribes brand-name but does not dispense it, and is not affiliated with Novo Nordisk (Wegovy) or Eli Lilly (Zepbound). Your own pharmacy fills the Rx.

Our Verdict

TMates edges out Gala with a score of 7.8/10 vs 7.2/10. Published pricing is not a like-for-like monthly comparison: Gala is from $149/mo; TMates is from $158/mo. TMates accepts insurance, which can significantly reduce your out-of-pocket costs.

Cheapest complete recurring price in our index

Eden Health GLP-1

$99/mo month-to-month, from $34 on a plan · 6.9/10 · Both

Both Gala and TMates start above the cheapest complete recurring program we track. Across all 54 providers in our index, the lowest price with affirmative medication, consultation, and shipping inclusion is Eden Health GLP-1 at $99/mo, price checked August 28, 2026. It scores 6.9/10 and is not the highest-scored provider in our full rankings, so this is a cost floor rather than a recommendation. Worth knowing before you decide.